TipRanks
Genmab A/S (DE:GE91)
FRANKFURT:GE91
Germany Market
GE91
Genmab
RESEARCH TOOLSreports

Genmab (GE91) Ratios

3 Followers

Genmab Ratios

DE:GE91's free cash flow for Q2 2026 was kr0.93. For the 2026 fiscal year, DE:GE91's free cash flow was decreased by kr and operating cash flow was kr0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.46 2.02 5.25 13.34 15.48
Quick Ratio
 2.44 2.01 5.24 13.32 15.48
Cash Ratio
 1.32 1.20 1.86 5.99 5.43
Solvency Ratio
 0.13 0.15 0.91 1.25 2.05
Operating Cash Flow Ratio
 0.78 0.83 1.46 2.97 2.15
Short-Term Operating Cash Flow Coverage
 3.04 4.35 0.00 0.00 0.00
Net Current Asset Value
kr -3.76B$ -4.13Bkr 18.74Bkr 29.46Bkr 25.38B
Leverage Ratios
Debt-to-Assets Ratio
 0.42 0.42 0.02 0.02 0.02
Debt-to-Equity Ratio
 0.89 0.93 0.03 0.02 0.02
Debt-to-Capital Ratio
 0.47 0.48 0.03 0.02 0.02
Long-Term Debt-to-Capital Ratio
 0.45 0.46 0.00 0.00 0.00
Financial Leverage Ratio
 2.10 2.20 1.25 1.12 1.10
Debt Service Coverage Ratio
 2.27 3.28 69.81 172.67 278.71
Interest Coverage Ratio
 4.98 20.49 55.86 197.07 298.43
Debt to Market Cap
 0.24 0.28 0.00 0.00 0.00
Interest Debt Per Share
 9.03 8.83 1.78 1.21 0.95
Net Debt to EBITDA
 2.71 2.78 -0.91 -2.37 -1.27
Profitability Margins
Gross Profit Margin
39.92%91.69%95.42%98.63%100.00%
EBIT Margin
14.06%34.01%43.13%34.64%48.02%
EBITDA Margin
14.45%35.91%45.05%36.10%50.64%
Operating Profit Margin
13.81%33.60%31.14%32.30%43.21%
Pretax Profit Margin
9.40%32.37%42.57%34.22%47.88%
Net Profit Margin
8.17%25.89%36.44%26.42%37.59%
Continuous Operations Profit Margin
8.17%25.89%36.44%26.42%37.59%
Net Income Per EBT
86.96%79.98%85.60%77.20%78.50%
EBT Per EBIT
68.05%96.32%136.71%105.94%110.82%
Return on Assets (ROA)
6.30%7.50%17.12%12.33%18.10%
Return on Equity (ROE)
13.58%16.52%21.38%13.77%19.98%
Return on Capital Employed (ROCE)
11.71%10.95%16.55%16.22%22.15%
Return on Invested Capital (ROIC)
9.91%8.54%14.13%12.49%17.34%
Return on Tangible Assets
23.97%28.45%25.36%12.37%18.19%
Earnings Yield
3.70%5.03%8.07%3.07%2.83%
Efficiency Ratios
Receivables Turnover
 7.53 3.24 3.22 3.33 2.54
Payables Turnover
 0.00 0.29 0.00 0.00 0.00
Inventory Turnover
 16.03 17.22 15.89 3.96 0.00
Fixed Asset Turnover
 37.97 13.33 81.59 10.04 10.97
Asset Turnover
 0.77 0.29 0.47 0.47 0.48
Working Capital Turnover Ratio
 6.31 0.31 0.81 0.58 0.61
Cash Conversion Cycle
 71.22 -1.12K 136.43 201.66 143.74
Days of Sales Outstanding
 48.45 112.69 113.45 109.61 143.74
Days of Inventory Outstanding
 22.77 21.20 22.97 92.06 0.00
Days of Payables Outstanding
 0.00 1.26K 0.00 0.00 0.00
Operating Cycle
 71.22 133.88 136.43 201.66 143.74
Cash Flow Ratios
Operating Cash Flow Per Share
 1.46 1.91 12.02 11.20 5.98
Free Cash Flow Per Share
 1.42 1.85 11.73 10.63 5.50
CapEx Per Share
 0.04 0.06 0.29 0.57 0.48
Free Cash Flow to Operating Cash Flow
 0.97 0.97 0.98 0.95 0.92
Dividend Paid and CapEx Coverage Ratio
 38.57 32.05 41.56 19.63 12.34
Capital Expenditure Coverage Ratio
 38.57 32.05 41.56 19.63 12.34
Operating Cash Flow Coverage Ratio
 0.17 0.22 7.55 9.58 6.55
Operating Cash Flow to Sales Ratio
 0.09 0.32 0.36 0.45 0.27
Free Cash Flow Yield
4.08%6.01%7.81%4.94%1.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.12 19.91 12.39 32.56 35.30
Price-to-Sales (P/S) Ratio
 2.21 5.14 4.51 8.60 13.27
Price-to-Book (P/B) Ratio
 3.57 3.28 2.65 4.48 7.05
Price-to-Free Cash Flow (P/FCF) Ratio
 24.50 16.65 12.81 20.23 53.53
Price-to-Operating Cash Flow Ratio
 23.84 16.13 12.50 19.20 49.20
Price-to-Earnings Growth (PEG) Ratio
 -0.32 -0.23 0.15 -1.56 0.42
Price-to-Fair Value
 3.57 3.28 2.65 4.48 7.05
Enterprise Value Multiple
 18.00 17.10 9.11 21.46 24.93
Enterprise Value
 25.08B 22.86B 88.33B 127.62B 183.16B
EV to EBITDA
 18.00 17.10 9.11 21.46 24.93
EV to Sales
 2.60 6.14 4.10 7.75 12.63
EV to Free Cash Flow
 28.83 19.88 11.65 18.22 50.95
EV to Operating Cash Flow
 28.09 19.26 11.37 17.29 46.82
Tangible Book Value Per Share
 -5.33 -5.83 33.76 47.80 41.50
Shareholders’ Equity Per Share
 9.71 9.39 56.78 47.95 41.72
Tax and Other Ratios
Effective Tax Rate
 0.13 0.20 0.14 0.23 0.21
Revenue Per Share
 15.72 5.99 33.30 24.99 22.18
Net Income Per Share
 1.29 1.55 12.14 6.60 8.34
Tax Burden
 0.87 0.80 0.86 0.77 0.79
Interest Burden
 0.67 0.95 0.99 0.99 1.00
Research & Development to Revenue
 0.19 0.42 0.45 0.46 0.38
SG&A to Revenue
 0.08 0.16 0.18 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.00 0.03 0.04 0.03
Income Quality
 1.04 1.23 0.99 1.31 0.56